Cargando…
CSF Biomarkers in COVID-19 Associated Encephalopathy and Encephalitis Predict Long-Term Outcome
Patients with coronavirus disease 2019 (COVID-19) frequently develop acute encephalopathy and encephalitis, but whether these complications are the result from viral-induced cytokine storm syndrome or anti-neural autoimmunity is still unclear. In this study, we aimed to evaluate the diagnostic and p...
Autores principales: | Guasp, Mar, Muñoz-Sánchez, Guillermo, Martínez-Hernández, Eugenia, Santana, Daniel, Carbayo, Álvaro, Naranjo, Laura, Bolós, Uma, Framil, Mario, Saiz, Albert, Balasa, Mircea, Ruiz-García, Raquel, Sánchez-Valle, Raquel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9035899/ https://www.ncbi.nlm.nih.gov/pubmed/35479062 http://dx.doi.org/10.3389/fimmu.2022.866153 |
Ejemplares similares
-
Limitations of a Commercial Assay as Diagnostic Test of Autoimmune Encephalitis
por: Ruiz-García, Raquel, et al.
Publicado: (2021) -
The diagnosis of anti-LGI1 encephalitis varies with the type of immunodetection assay and sample examined
por: Muñoz-Sánchez, Guillermo, et al.
Publicado: (2022) -
Thymoma and Autoimmune Encephalitis: Clinical Manifestations and Antibodies
por: Guasp, Mar, et al.
Publicado: (2021) -
Clinical features of seronegative, but CSF antibody-positive, anti-NMDA receptor encephalitis
por: Guasp, Mar, et al.
Publicado: (2020) -
Clinically reversible ustekinumab-induced encephalopathy: case report and review of the literature
por: Sarto, Jordi, et al.
Publicado: (2022)